Diagnostic Characteristics of a Serum Biomarker in Patients With Positron Emission Tomography Scans

Annals of Thoracic Surgery

Volumn 89, Issue 6, 2010, Pages 1724-1729

  Grogan, Eric L ^a,c   Deppen, Stephen ^a   Pecot, Chad V ^b,c   Putnam Jr , Joe B ^a,c   Nesbitt, Jonathan C ^a,c   Shyr, Yu ^a   Rajanbabu, Rama ^b   Ory, Bridget ^b   Lambright, Eric S ^a,c   Massion, Pierre P ^b,c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77952306751     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.03.008     Document Type: Article

References (19)

1. Grogan E.L., Stukenborg G.J., Nagji A.S., et al. Radiotracer-guided thoracoscopic resection is a cost-effective technique for the evaluation of subcentimeter pulmonary nodules. Ann Thorac Surg 86 (2008) 934-940
2. Crestanello J.A., Allen M.S., Jett J.R., et al. Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg 128 (2004) 254-259
3. Smith M.A., Battafarano R.J., Meyers B.F., et al. Prevalence of benign disease in patients undergoing resection for suspected lung cancer. Ann Thorac Surg 81 (2006) 1824-1829
4. Yildiz P.B., Shyr Y., Rahman J.S., et al. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol 2 (2007) 893-901
5. Patz Jr. E.F., Campa M.J., Gottlin E.B., et al. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 25 (2007) 5578-5583
6. Ferrigno D., Buccheri G., and Giordano C. Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC). Lung Cancer 41 (2003) 311-320
7. Greenberg A.K., and Lee M.S. Biomarkers for lung cancer: clinical uses. Curr Opin Pulm Med 13 (2007) 249-255
8. Khan N., Cromer C.J., Campa M., and Patz Jr. E.F. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer 101 (2004) 379-384
9. Molina R., Filella X., and Auge J.M. ProGRP: a new biomarker for small cell lung cancer. Clin Biochem 37 (2004) 505-511
10. Okada M., Nishio W., Sakamoto T., et al. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg 78 (2004) 216-221
11. Pujol J.L., Quantin X., Jacot W., et al. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 39 (2003) 131-138
12. Siemes C., Visser L.E., Coebergh J.W., et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24 (2006) 5216-5222
13. Yang S.Y., Xiao X.Y., Zhang W.G., et al. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer 5 (2005) 83
14. Han K.Q., Huang G., Gao C.F., et al. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Am J Clin Oncol 31 (2008) 133-139
15. Howard B.A., Wang M.Z., Campa M.J., et al. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. Proteomics 3 (2003) 1720-1724
16. Pepe M.S., Feng Z., Janes H., Bossuyt P.M., and Potter J.D. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst 100 (2008) 1432-1438
17. Jessup J.M., Lively T.G., and Taube S.E. Program for the Assessment of Clinical Cancer Tests (PACCT): implementing promising assays into clinical practice. Expert Rev Mol Diagn 5 (2005) 271-273
18. Rivera M.P., and Mehta A.C. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed). Chest 132 3 Suppl (2007) 131S-148S
19. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354 (1999) 99-105